Updated Jul 16, 2026
Lee Sam is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Sam Lee is the President and Co-CEO of Cocrystal Pharma, Inc., a biotechnology company focused on developing antiviral therapeutics. He has been involved in the company's efforts to create innovative antiviral drugs targeting various viruses.
| Role | President and Co-CEO |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-10-11 | COCP | Cocrystal Pharma, Inc. | A — Grant or award | 40.0K | — |
Sam Lee is the President and Co-CEO of Cocrystal Pharma, Inc., a biotechnology company focused on developing antiviral therapeutics. He has been involved in the company's efforts to create innovative antiviral drugs targeting various viruses.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lee Sam profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.